Drug Shortage Report for LOSARTAN HCT
| Report ID | 120600 |
| Drug Identification Number | 02388979 |
| Brand name | LOSARTAN HCT |
| Common or Proper name | LOSARTAN HCT |
| Company Name | SIVEM PHARMACEUTICALS ULC |
| Market Status | DORMANT |
| Active Ingredient(s) | LOSARTAN POTASSIUM HYDROCHLOROTHIAZIDE |
| Strength(s) | 100MG 12.5MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 30 |
| ATC code | C09DA |
| ATC description | ANGIOTENSIN II ANTAGONISTS, COMBINATIONS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2020-08-17 |
| Actual start date | 2020-10-09 |
| Estimated end date | 2021-05-07 |
| Actual end date | 2021-05-07 |
| Shortage status | Resolved |
| Updated date | 2021-05-14 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 4705 DOBRIN STREET SAINT-LAURENT, QUEBEC CANADA H4R 2P7 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.